Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics

Psychopharmacology

Volumn 201, Issue 3, 2008, Pages 383-389

  Zhang, Xiang Yang ^a   Cao, Lian Yuan ^b   Song, Cai ^c   Wu, Gui Ying ^a   Chen, Da Chun ^b   Qi, Ling Yan ^b   Wang, Fan ^b   Xiu, Mei Hong ^b   Chen, Song ^b   Zhang, Yingyang ^a,b   Lu, Lin ^d   Kosten, Therese A ^a   Kosten, Thomas R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^d PEKING UNIVERSITY   (China)

Author keywords

Cytokine; Immune; Nicotine; Schizophrenia; Smoking

Indexed keywords

CLOZAPINE; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; NEUROLEPTIC AGENT; RISPERIDONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; LONG TERM CARE; MALE; NONHUMAN; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING;

AGE FACTORS; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; CLOZAPINE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56549094973     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1295-4     Document Type: Article

References (51)

1. LE Adler LJ Hoffer J Griffith MC Waldo R Freedman 1992 Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics Biol Psychiatry 32 607 616
2. LE Adler LD Hoffer A Wiser R Freedman 1993 Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am J Psychiatry 150 1856 1861
3. LE Adler A Olincy M Waldo JG Harris J Griffith K Stevens K Flach H Nagamoto P Bickford S Leonard R Freedman 1998 Schizophrenia, sensory gating, and nicotinic receptors Schizophr Bull 24 189 202
4. I Baker J Masserano RJ Wyatt 1996 Serum cytokine concentrations in patients with schizophrenia Schizophr Res 20 199 203
5. C Caruso G Candore D Cigna AT Colucc MA Modica 1993 Biological significance of soluble IL-2 receptor Mediators Inflamm 2 3 21
6. CL Cazzullo E Sacchetti A Galluzzo A Panariello F Colombo A Zagliani M Clerici 2001 Cytokine profiles in drug-naive schizophrenic patients Schizophr Res 47 293 298
7. KN Chengappa R Ganguli ZW Yang G Shurin JS Brar RS Rabin 1995 Impaired mitogen (PHA) responsiveness and increased autoantibodies in Caucasian schizophrenic patients with the HLA B8/DR3 phenotype Biol Psychiatry 37 546 549
8. GW Dalack DJ Healy JH Meador-Woodruff 1998 Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings Am J Psychiatry 155 1490 1501
9. J de Leon FJ Diaz 2005 A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors Schizophr Res 76 135 157
10. J de Leon E Becona M Gurpegui A Gonzalez-Pinto FJ Diaz 2002 The association between high nicotine dependence and severe mental illness may be consistent across countries J Clin Psychiatry 63 812 816
11. R Freedman LE Adler P Bickford W Byerley H Coon CM Cullum JM Griffith JG Harris S Leonard C Miller 1994 Schizophrenia and nicotinic receptors Harv Rev Psychiatry 2 179 192
12. R Freedman H Coon M Myles-Worsley A Orr-Urtreger A Olincy A Davis M Polymeropoulos J Holik J Hopkins M Hoff J Rosenthal MC Waldo F Reimherr P Wender J Yaw DA Young CR Breese C Adams D Patterson LE Adler L Kruglyak S Leonard W Byerley 1997 Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci U S A 94 587 592
13. H Friedman S Pross TW Klein 2006 Addictive drugs and their relationship with infectious diseases FEMS Immunol Med Microbiol 47 330 342
14. R Ganguli JS Brar KNR Chengappa M Deleo ZW Yang G Shurin 1995 Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients Arch Gen Psychiatry 52 668 672
15. Y Geng SM Savage S Razani-Boroujerdi ML Sopori 1996 Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy J Immunol 156 2384 2390
16. DC Goff DC Henderson E Amico 1992 Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects Am J Psychiatry 149 1189 1194
17. N Hallquist A Hakki L Wecker H Friedman S Pross 2000 Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1- versus Th2-type cytokines Proc Soc Exp Biol Med 224 141 146
18. AE Henneberg S Horter S Ruffert 1994 Increased prevalence of antibrain antibodies in the sera from schizophrenic patients Schizophr Res 14 15 22
19. YK Kim L Kim MS Lee 2000 Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics Schizophr Res 44 165 175
20. DG Kirch 1993 Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal Schizophr Bull 19 355 370
21. Z Kronfol DG Remick 2000 Cytokines and the brain: implications for clinical psychiatry Am J Psychiatry 157 683 694
22. V Kumari P Postma 2005 Nicotine use in schizophrenia: the self medication hypotheses Neurosci Biobehav Rev 29 1021 1034
23. T Lencz TV Morgan M Athanasiou B Dain CR Reed JM Kane R Kucherlapati AK Malhotra 2007 Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia Mol Psychiatry 12 572 580
24. S Leonard J Gault J Hopkins J Logel R Vianzon M Short C Drebing R Berger D Venn P Sirota G Zerbe A Olincy RG Ross LE Adler R Freedman 2002 Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia Arch Gen Psychiatry 59 1085 1096
25. J Licinio JP Seibyl M Altemus DS Charney JH Krystal 1993 Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 150 1408 1410
26. A Lin G Kenis S Bignotti GJ Tura R DeJong E Bosmans R Pioli C Altamura S Scharpe M Maes 1998 The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 Schizophr Res 32 9 15
27. A LLerena A de la Rubia EM Penas-Lledo FJ Diaz J de Leon 2003 Schizophrenia and tobacco smoking in a Spanish psychiatric hospital Schizophr Res 60 313 317
28. JB Lohr K Flynn 1992 Smoking and schizophrenia Schizophr Res 8 93 102
29. M Maes HY Meltzer E Bosmans 1994 Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine Acta Psychiatr Scand 89 346 351
30. M Maes E Bosmans J Calabrese R Smith H Meltzer 1995 Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers J Psychiatr Res 29 141 152
31. M Maes L Bocchio Chiavetto S Bignotti GJ Battisa Tura R Pioli F Boin G Kenis E Bosmans R de Jongh CA Altamura 2002 Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor Schizophr Res 54 281 291
32. Y Mamata A Hakki Y Yamamoto C Newton TW Klein S Pross H Friedman 2005 Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells Int Immunopharmacol 5 749 756
33. RG McCreadie 2002 Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study Br J Psychiatry 181 321 325
34. N Muller M Schwarz 2006 Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission Neurotox Res 10 131 148
35. N Muller E Hofschuster M Ackenheil R Eckstein 1993 T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy Acta Psychiatr Scand 87 66 71
36. N Muller M Empl M Riedel M Schwarz M Ackenheil 1997 Neuroleptic treatment increases soluble IL-receptors and decreases soluble IL-6 receptors in schizophrenia Eur Arch Psychiatry Clin Neurosci 247 308 313
37. N Muller M Reidel M Ackenheil MJ Schwarz 1999 The role of immune function in schizophrenia: an overview Eur Arch Psychiatry Clin Neurosci 249 suppl 4 62 68
38. J Naudin C Kapo B Giusano JL Mege JM Azorin 1997 A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res 26 227 233
39. Y Ouyang N Virasch P Hao MT Aubrey N Mukerjee BE Bierer BM Freed 2000 Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts J Allergy Clin Immunol 106 280 287
40. MH Rapaport JB Lohr 1994 Serum interleukin-2 receptors in neuroleptic naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia Acta Psychiatr Scand 90 311 315
41. K Rasmussen JF Czachura 1995 Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons NeuroReport 7 329 332
42. RC Smith A Singh M Infante A Khandat A Kloos 2002 Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia Neuropsychopharmacology 27 479 497
43. M Sopori 2002 Effects of cigarette smoke on the immune system Nat Rev Immunol 2 372 377
44. ML Sopori W Kozak 1998 Immunomodulatory effects of cigarette smoke J Neuroimmunol 83 148 156
45. S Theodoropoulou G Spanakos CN Baxevanis M Economou AD Gritzapis MP Papamichail CN Stefanis 2001 Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients Schizophr Res 47 13 25
46. HM Xu J Wei GP Hemmings 1994 Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia Br J Psychiatry 164 251 253
47. XY Zhang DF Zhou LY Cao PY Zhang GY Wu 2002 Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia J Psychiatr Res 36 331 336
48. XY Zhang DF Zhou PY Zhang GY Wu LY Cao YC Shen 2002 Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology Schizophr Res 57 2-3 247 258
49. XY Zhang DF Zhou LY Cao PY Zhang GY Wu YC Shen 2004 Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia J Clin Psychiatry 65 940 947
50. XY Zhang DF Zhou LY Cao GY Wu YC Shen 2005 Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics Neuropsychopharmacol 30 1532 1538
51. DM Ziedonis TR Kosten WM Glazer RJ Frances 1994 Nicotine dependence and schizophrenia Hosp Community Psychiatry 45 204 206